Cargando…
Anti-CD19 chimeric antigen receptor T-cell therapy in B-cell lymphomas: current status and future directions
AIMS: To review recent data and relevant of the role of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for B-cell non-Hodgkin lymphoma (NHL). METHODS: Review and compilation of the most recent and relevant data published in full text and abstract forms of anti-CD19 CAR T-cell therapy for B...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445151/ https://www.ncbi.nlm.nih.gov/pubmed/34540198 http://dx.doi.org/10.2217/ijh-2020-0021 |